BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Cassava Sciences Provides a Business Update - January 7, 2025

  January 8, 2025

   · 

  8 min read
• Press Releases

  BD To Host Virtual 2025 Annual Meeting of Shareholders

  January 8, 2025

   · 

  2 min read
• Press Releases

  Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  January 8, 2025

   · 

  5 min read
• Press Releases

  Roche purchases shares in tender offer for Poseida Therapeutics, Inc.

  January 8, 2025

   · 

  5 min read
• Press Releases

  Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies

  January 8, 2025

   · 

  3 min read
• Press Releases

  Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders

  January 8, 2025

   · 

  5 min read
• Press Releases

  Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

  January 8, 2025

   · 

  18 min read
• Press Releases

  Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025

  January 8, 2025

   · 

  5 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000

  January 8, 2025

   · 

  3 min read
• Press Releases

  Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

  January 8, 2025

   · 

  11 min read